Computer model helps cirrhosis patients get right blood thinner dose faster
NCT ID NCT07571460
First seen May 07, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study tested whether a computer program called Simcyp could help doctors choose the right starting dose of warfarin (a blood thinner) for people with liver cirrhosis and a blood clot in the portal vein. Twenty-one adults with mild to moderate cirrhosis took part. The goal was to see if the program helped patients reach a safe, effective blood-thinning level more quickly and safely than standard dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kafrelsheikh University
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.